Financial Partners Group (Kansas)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$275K Buy
1,484
+10
+0.7% +$1.86K 0.04% 168
2025
Q1
$309K Sell
1,474
-678
-32% -$142K 0.05% 143
2024
Q4
$382K Sell
2,152
-37
-2% -$6.57K 0.06% 122
2024
Q3
$432K Buy
2,189
+8
+0.4% +$1.58K 0.06% 117
2024
Q2
$374K Sell
2,181
-499
-19% -$85.6K 0.06% 122
2024
Q1
$488K Buy
2,680
+1,019
+61% +$186K 0.08% 108
2023
Q4
$257K Sell
1,661
-52
-3% -$8.06K 0.05% 138
2023
Q3
$236K Buy
1,713
+278
+19% +$38.4K 0.05% 137
2023
Q2
$212K Sell
1,435
-1,116
-44% -$165K 0.04% 146
2023
Q1
$407K Buy
2,551
+210
+9% +$33.5K 0.09% 98
2022
Q4
$360K Buy
+2,341
New +$360K 0.08% 110
2022
Q3
Sell
-1,356
Closed -$208K 144
2022
Q2
$208K Buy
1,356
+6
+0.4% +$920 0.05% 138
2022
Q1
$219K Buy
+1,350
New +$219K 0.05% 151